Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation

References

• AmbrosiniGAdidaCAltieriDCA novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNat Med1997389179219256286
   PubMed Web of Science ®Google Scholar
• JeyaprakashAAKleinURLindnerDEbertJNiggEAContiEStructure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel togetherCell2007131227128517956729
   PubMed Web of Science ®Google Scholar
• RuchaudSCarmenaMEarnshawWCChromosomal passengers: conducting cell divisionNat Rev Mol Cell Biol200781079881217848966
   PubMed Web of Science ®Google Scholar
• VaderGMedemaRHLensSMThe chromosomal passenger complex: guiding Aurora-B through mitosisJ Cell Biol2006173683383716769825
   PubMed Web of Science ®Google Scholar
• NiggEAMitotic kinases as regulators of cell division and its check-pointsNat Rev Mol Cell Biol200121213211413462
   PubMed Web of Science ®Google Scholar
• CarmenaMEarnshawWCThe cellular geography of aurora kinasesNat Rev Mol Cell Biol200341184285414625535
   PubMed Web of Science ®Google Scholar
• DohiTBeltramiEWallNRPlesciaJAltieriDCMitochondrial survivin inhibits apoptosis and promotes tumorigenesisJ Clin Invest200411481117112715489959
   PubMed Web of Science ®Google Scholar
• LiFAmbrosiniGChuEYControl of apoptosis and mitotic spindle checkpoint by survivinNature199839667115805849859993
   PubMed Web of Science ®Google Scholar
• TammIWangYSausvilleEIAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugsCancer Res19985823531553209850056
   PubMed Web of Science ®Google Scholar
• AsanumaKKobayashiDFuruyaDTsujiNYagihashiAWatanabeNA role for survivin in radioresistance of pancreatic cancer cellsJpn J Cancer Res20029391057106212359060
   PubMedGoogle Scholar
• BadranAYoshidaAIshikawaKIdentification of a novel splice variant of the human anti-apoptopsis gene survivinBiochem Biophys Res Commun2004314390290714741722
   PubMed Web of Science ®Google Scholar
• CaldasHHonseyLEAlturaRASurvivin 2alpha: a novel Survivin splice variant expressed in human malignanciesMol Cancer2005411115743529
   PubMed Web of Science ®Google Scholar
• CaldasHJiangYHollowayMPSurvivin splice variants regulate the balance between proliferation and cell deathOncogene200524121994200715688031
   PubMed Web of Science ®Google Scholar
• ConwayEMPollefeytSCornelissenJThree differentially expressed survivin cDNA variants encode proteins with distinct anti-apoptotic functionsBlood20009541435144210666222
   PubMed Web of Science ®Google Scholar
• SampathJPelusLMAlternative splice variants of survivin as potential targets in cancerCurr Drug Discov Technol20074317419117986000
   PubMedGoogle Scholar
• ZhuNGuLFindleyHWLiFZhouMAn alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapyOncogene200423457545755115334064
   PubMed Web of Science ®Google Scholar
• WuttigDKunzeDFuesselSAre overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?Int J Oncol20073061317132417487351
   PubMed Web of Science ®Google Scholar
• LingXYangJTanDDifferential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)Lung Cancer200549335336115936846
   PubMed Web of Science ®Google Scholar
• SpanPNTjan-HeijnenVCHeuvelJJde KokJBFoekensJASweepFCDo the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?Clin Chem20065291693170016873289
   PubMed Web of Science ®Google Scholar
• LiFRole of survivin and its splice variants in tumorigenesisBr J Cancer200592221221615611788
   PubMed Web of Science ®Google Scholar
• FangusaroJRJiangYHollowayMPSurvivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcomeBr J Cancer200592235936515655550
   PubMed Web of Science ®Google Scholar
• MirzaAMcGuirkMHockenberryTNHuman survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathwayOncogene200221172613262211965534
   PubMed Web of Science ®Google Scholar
• LingXChengQBlackJDLiFForced expression of survivin-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivinJ Biol Chem200728237272042721417656368
   PubMed Web of Science ®Google Scholar
• MahotkaCWenzelMSpringerEGabbertHEGerharzCDSurvivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic propertiesCancer Res199959246097610210626797
   PubMed Web of Science ®Google Scholar
• KnauerSKBierCSchlagPThe survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex proteinCell Cycle20076121502150917582222
   PubMed Web of Science ®Google Scholar
• KriegAMahotkaCKriegTExpression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progressionBr J Cancer200286573774311875736
   PubMed Web of Science ®Google Scholar
• MahotkaCKriegTKriegADistinct in vivo expression patterns of survivin splice variants in renal cell carcinomasInt J Cancer20021001303612115583
   PubMed Web of Science ®Google Scholar
• ChengZHuLFuWZhangQLiaoXExpression of survivin and its splice variants in gastric cancerJ Huazhong Univ Sci Technolog Med Sci200727439339817828494
   PubMedGoogle Scholar
• YamadaYKuroiwaTNakagawaTTranscriptional expression of survivin and its splice variants in brain tumors in humansJ Neurosurg200399473874514567610
   PubMed Web of Science ®Google Scholar
• AtlasiYMowlaSJZiaeeSADifferential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancerCancer Detect Prev200932430831319186007
   PubMedGoogle Scholar
• BoidotRVegranFLizard-NacolSPredictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapyInt J Mol Med200923228529119148555
   PubMed Web of Science ®Google Scholar
• De MariaSPannoneGBufoPSurvivin gene-expression and splicing isoforms in oral squamous cell carcinomaJ Cancer Res Clin Oncol2009135110711618642030
   PubMed Web of Science ®Google Scholar
• FutakuchiHUedaMKandaKFujinoKYamaguchiHNodaSTranscriptional expression of survivin and its splice variants in cervical carcinomasInt J Gynecol Cancer20071751092109817877643
   PubMed Web of Science ®Google Scholar
• HeXFWenDGHouJQHeJCenJNExpressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significanceAi Zheng200928111209121319895744
   PubMedGoogle Scholar
• NakanoJHuangCLiuDThe clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancersBr J Cancer20089861109111718283319
   PubMed Web of Science ®Google Scholar
• NouraeeNMowlaSJOzhandAParvinMZiaeeSAHatefiNExpression of survivin and its spliced variants in bladder tumors as a potential prognostic markerUrol J20096210110819472128
   PubMed Web of Science ®Google Scholar
• VegranFBoidotROudinCDef rainCRebucciMLizard-NacolSAssociation of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancerOncogene200726229029716847456
   PubMed Web of Science ®Google Scholar
• UrenAGBeilharzTO’ConnellMJRole for yeast inhibitor of apoptosis (IAP)-like proteins in cell divisionProc Natl Acad Sci U S A19999618101701017510468581
   PubMed Web of Science ®Google Scholar
• SpeliotesEKUrenAVauxDHorvitzHRThe survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzoneMol Cell20006221122310983970
   PubMed Web of Science ®Google Scholar
• DeguchiMShirakiKInoueHExpression of survivin during liver regenerationBiochem Biophys Res Commun20022971596412220508
   PubMed Web of Science ®Google Scholar